BE879107A - Peptides apparentes a la somatostatine et leur utilisation therapeutique - Google Patents

Peptides apparentes a la somatostatine et leur utilisation therapeutique

Info

Publication number
BE879107A
BE879107A BE1/9543A BE1009543A BE879107A BE 879107 A BE879107 A BE 879107A BE 1/9543 A BE1/9543 A BE 1/9543A BE 1009543 A BE1009543 A BE 1009543A BE 879107 A BE879107 A BE 879107A
Authority
BE
Belgium
Prior art keywords
somatostatin
therapeutic use
related peptides
peptides
therapeutic
Prior art date
Application number
BE1/9543A
Other languages
English (en)
Inventor
J E Shields
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BE879107A publication Critical patent/BE879107A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/16Somatostatin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE1/9543A 1978-10-02 1979-10-01 Peptides apparentes a la somatostatine et leur utilisation therapeutique BE879107A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/948,117 US4202802A (en) 1978-10-02 1978-10-02 Peptides related to somatostatin

Publications (1)

Publication Number Publication Date
BE879107A true BE879107A (fr) 1980-04-01

Family

ID=25487300

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/9543A BE879107A (fr) 1978-10-02 1979-10-01 Peptides apparentes a la somatostatine et leur utilisation therapeutique

Country Status (9)

Country Link
US (1) US4202802A (fr)
EP (1) EP0011366A3 (fr)
JP (1) JPS5549344A (fr)
BE (1) BE879107A (fr)
CA (1) CA1129846A (fr)
FR (2) FR2439181A1 (fr)
GB (1) GB2030572B (fr)
IL (1) IL58337A0 (fr)
LU (1) LU81733A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2458539A1 (fr) * 1979-06-11 1981-01-02 Lilly Co Eli Peptides apparentes a la somatostatine, leur preparation et leur utilisation therapeutique
US4369179A (en) * 1979-12-14 1983-01-18 Ciba-Geigy Corporation Acylpeptides
US4585740A (en) * 1983-05-03 1986-04-29 The Whittier Institute For Diabetes And Endocrinology Prolactin immunoassay using synthetic peptide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904594A (en) * 1973-07-02 1975-09-09 Salk Inst For Biological Studi Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
DE2416048A1 (de) * 1974-04-03 1975-10-30 Hoechst Ag Neue peptide mit biologischer wirkung
US4372884A (en) * 1975-08-06 1983-02-08 The Salk Institute For Biological Studies Pharmaceutically active peptides
IL51508A0 (en) * 1976-03-08 1977-06-30 Lilly Co Eli Sonatostatin analogs and intermediates thereto
US4100117A (en) * 1977-04-21 1978-07-11 Eli Lilly And Company Somatostatin analogs and intermediates thereto

Also Published As

Publication number Publication date
JPS5549344A (en) 1980-04-09
IL58337A0 (en) 1979-12-30
FR2453138A1 (fr) 1980-10-31
FR2439181A1 (fr) 1980-05-16
CA1129846A (fr) 1982-08-17
US4202802A (en) 1980-05-13
EP0011366A3 (fr) 1982-02-10
LU81733A1 (fr) 1980-01-24
GB2030572A (en) 1980-04-10
GB2030572B (en) 1982-10-13
EP0011366A2 (fr) 1980-05-28

Similar Documents

Publication Publication Date Title
LU80922A1 (fr) 9-amino-et imino-dibenzopyrannes et leur utilisation therapeutique
LU81458A1 (fr) Phenethanolamines et leur utilisation therapeutique
LU81439A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
BE873883A (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes, et leur utilisation therapeutique
FI792802A (fi) Inhalator
BE875240A (fr) Anode a gel et poudre
BE877391A (fr) Phenethanolamines optiquement actives et leur utilisation therapeutique
BE880220A (fr) 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur utilisation therapeutique, leur preparation et les intermediaires appropries
BE875241A (fr) Anode a gel et poudre
FR2404629B1 (fr) Nouveaux tetrapeptides et leur utilisation therapeutique
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE872134A (fr) Nouvelles indolo (2,3,a) quinolizidines, leur preparation et leur utilisation therapeutique
BE872990A (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
BE880884A (fr) Composition therapeutique a activite antithrombotique et anti-agregante plaquettaire
BE879107A (fr) Peptides apparentes a la somatostatine et leur utilisation therapeutique
BE868953A (fr) Peptides, leur preparation et leur utilisation
BE877328A (fr) Octahydro-2h-pyrrolo (3,4-g) quinoleines et leur utilisation therapeutique
LU81437A1 (fr) 2-azaergolines et 2-aza-8(ou 9)ergolenes et leur utilisation therapeutique
BE874430A (fr) 2,3-dihydroimidazo (1,2,c) pyrimidines substituees et leur utilisation therapeutique
LU81454A1 (fr) R-n-(2-phenyl-2-hydroxyethyl)-3-phenylpropylamines et leur utilisation therapeutique
BE883608A (fr) Peptides apparentes a la somatostatine leur preparation et leur utilisation therapeutique
BE874662A (fr) Benzocycloheptapyrannes et leur utilisation therapeutique
BE876680A (fr) Arylalkyl- et aryloxyalkyl- phosphonates, leur preparation et leur utilisation therapeutique
BE871724A (fr) 4-desacetoxy-4 alpha-hydroxyindole-dihydroindoles et leur utilisation therapeutique
BE882167A (fr) (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique